Responsible for building and leading a world class Bioprocess R&D organization at the Merck Research Laboratories.  During this period, mostly as Vice President, Barry was involved in the development, transfer to manufacturing, licensure and launch for many key products including :

  • MEVACOR ® (A natural product used for cholesterol lowering)

  • ZOCOR ® (Derived from Mevacaor)

  • IVOMEC ® (Anti parasitic drug for both animals and humans)

  • CANCIDAS ® (A natural product with excellent anti fungal activity)

  • RECOMBIVAX HB ® (Vaccine against Hepatitis B)

  • VAQTA ® (Hepatitis A Vaccine)

  • VARIVAX ® (Chicken pox vaccine)

  • COMVAX ® (Combination pediatric vaccine)

  • ROTATEQ ® (Rotavirus vaccine for infant diarrhea)

  • ZOSTAVAX ® (Vaccine against shingles)

  • GARDASIL ® (Vaccine against Human Papillomovirus HPV)